156 related articles for article (PubMed ID: 1347312)
1. Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense.
Birkland TP; Sypek JP; Wyler DJ
J Leukoc Biol; 1992 Mar; 51(3):296-9. PubMed ID: 1347312
[TBL] [Abstract][Full Text] [Related]
2. Antileishmanial defense in macrophages triggered by tumor necrosis factor expressed on CD4+ T lymphocyte plasma membrane.
Sypek JP; Wyler DJ
J Exp Med; 1991 Oct; 174(4):755-9. PubMed ID: 1680956
[TBL] [Abstract][Full Text] [Related]
3. Th2 lymphocyte clone can activate macrophage antileishmanial defense by a lymphokine-independent mechanism in vitro and can augment parasite attrition in vivo.
Sypek JP; Matzilevich MM; Wyler DJ
Cell Immunol; 1991 Mar; 133(1):178-86. PubMed ID: 1825032
[TBL] [Abstract][Full Text] [Related]
4. T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.
Sypek JP; Wyler DJ
Infect Immun; 1990 May; 58(5):1146-52. PubMed ID: 2323812
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation for antileishmanial defense by an apparently novel mechanism.
Wyler DJ; Beller DI; Sypek JP
J Immunol; 1987 Feb; 138(4):1246-9. PubMed ID: 3100630
[TBL] [Abstract][Full Text] [Related]
6. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
Panosian CB; Sypek JP; Wyler DJ
J Immunol; 1984 Dec; 133(6):3358-65. PubMed ID: 6208278
[TBL] [Abstract][Full Text] [Related]
7. Antigen recognition by effector T cells in antileishmanial defense.
Sypek JP; Panosian CB; Wyler DJ
J Infect Dis; 1985 Nov; 152(5):1057-63. PubMed ID: 2413143
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gamma interferon, tumor necrosis factor, and direct cell contact in activation of antimycobacterial defense in murine macrophages.
Sypek JP; Jacobson S; Vorys A; Wyler DJ
Infect Immun; 1993 Sep; 61(9):3901-6. PubMed ID: 8359912
[TBL] [Abstract][Full Text] [Related]
9. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.
Green SJ; Crawford RM; Hockmeyer JT; Meltzer MS; Nacy CA
J Immunol; 1990 Dec; 145(12):4290-7. PubMed ID: 2124240
[TBL] [Abstract][Full Text] [Related]
10. Cytokine interactions in experimental cutaneous leishmaniasis.
Solbach W; Röllinghoff M; Stenger S; Bogdan C
Behring Inst Mitt; 1991 Feb; (88):230-8. PubMed ID: 1904708
[TBL] [Abstract][Full Text] [Related]
11. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
Sypek JP; Panosian CB; Wyler DJ
J Immunol; 1984 Dec; 133(6):3351-7. PubMed ID: 6333458
[TBL] [Abstract][Full Text] [Related]
12. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
Muñoz-Fernández MA; Fernández MA; Fresno M
Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
[TBL] [Abstract][Full Text] [Related]
13. Cell contact-mediated macrophage activation for antileishmanial defence: mapping of the genetic restriction to the I region of the MHC.
Sypek JP; Wyler DJ
Clin Exp Immunol; 1985 Dec; 62(3):449-57. PubMed ID: 3936653
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of lymphokine-resistant Leishmania to cell contact-mediated macrophage activation.
Sypek JP; Wyler DJ
J Infect Dis; 1988 Aug; 158(2):392-7. PubMed ID: 3136211
[TBL] [Abstract][Full Text] [Related]
15. Regulation of activated macrophage antimicrobial activities. Cooperation of lymphokines for induction of resistance to infection.
Davis CE; Belosevic M; Meltzer MS; Nacy CA
J Immunol; 1988 Jul; 141(2):627-35. PubMed ID: 3133412
[TBL] [Abstract][Full Text] [Related]
16. Phagocytosis of Leishmania enhances macrophage activation by IFN-gamma and lipopolysaccharide.
Corradin SB; Mauël J
J Immunol; 1991 Jan; 146(1):279-85. PubMed ID: 1898602
[TBL] [Abstract][Full Text] [Related]
17. T cells which do not express membrane tumor necrosis factor-alpha activate macrophage effector function by cell contact-dependent signaling of macrophage tumor necrosis factor-alpha production.
Suttles J; Miller RW; Tao X; Stout RD
Eur J Immunol; 1994 Aug; 24(8):1736-42. PubMed ID: 8056032
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis enhances murine macrophage activation by interferon-gamma and tumor necrosis factor-alpha.
Corradin SB; Buchmüller-Rouiller Y; Mauël J
Eur J Immunol; 1991 Oct; 21(10):2553-8. PubMed ID: 1915557
[TBL] [Abstract][Full Text] [Related]
19. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
20. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
Belosevic M; Davis CE; Meltzer MS; Nacy CA
J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
